Advisory Board

3BP's founding team comprises renowned experts in peptide drug discovery and nuclear medicine. Its members have a broad background in industrial drug development at both pharmaceutical and biotech companies. In addition, they have extensive academic experience ranging from clinical research in oncology to imaging and radiotherapy.

3BP - Advisory Board
Prof. M. Bräutigam
Imaging
Ex-Bayer Schering/
Freie Universität Berlin

Prof. M Bräutigam

Dr. J. F. Kapp
Clinical development
Ex-Schering/ Warner-Lambert

Dr. J. F. Kapp

Dr. J. Knolle
Drug development
Ex-Hoechst/ HMR/ Axys/ Jerini AG (Head of R&D)

Dr. J. Knolle

Prof. H. Mäcke
Radiochemistry
Ex-Basel University
Freiburg University

Prof. H. Mäcke

Prof. J. C. Reubi
Target validation
Ex-Novartis
University of Berne

Prof. J. C. Reubi

Prof. J. Schneider-Mergener
Drug development
Founder and former CEO of Jerini AG
Charité Berlin

Prof. J. Schneider-Mergener

Prof. B. Wiedenmann
Clinical practice
Hepatology,
gastroenterology
Charité Berlin

Prof. B. Wiedenmann

Experienced founders. Active advisors of 3BP.Shareholding founders. Active advisors of 3BP